NYLI Global Equity R&D Leaders ETF
WRND
NASDAQ Global Market- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- NYLI Global Equity R&D Leaders ETF (Ticker: WRND) is an exchange-traded fund that seeks to provide investment results corresponding to the performance of the Solactive New York Life Global Equity R&D Leaders Index, focusing on global companies demonstrating leadership in research and development spending relative to their peers. The ETF invests primarily in equity securities of large- and mid-cap companies across developed and emerging markets worldwide, selected and weighted based on proprietary R&D intensity metrics that emphasize innovation-driven growth; it employs a passive management strategy with full replication of the underlying index, quarterly rebalancing, and securities lending to enhance returns. Launched in 2024 by New York Life Investments, a division of New York Life Insurance Company founded in 1845 and headquartered in New York City, the fund targets institutional and retail investors seeking exposure to high-R&D sectors such as technology, healthcare, and consumer discretionary, with geographic operations spanning North America, Europe, Asia-Pacific, and emerging markets. The fund's portfolio includes approximately 100 holdings, with top allocations to leading innovators like technology giants, pharmaceutical firms, and semiconductor manufacturers that consistently rank high in R&D expenditure as a percentage of sales; representative sectors encompass information technology (over 40%), health care (around 25%), and industrials, featuring companies such as NVIDIA, Roche Holding, and Novo Nordisk, though exact weights fluctuate with index reconstitutions. WRND offers daily liquidity on major U.S. exchanges, competitive expense ratio of 0.50%, and dividend distributions, appealing to long-term growth-oriented portfolios emphasizing future-oriented innovation leaders. In recent developments, New York Life Investments expanded its ETF lineup with the WRND launch in mid-2024, marking a strategic entry into thematic equity strategies amid rising investor demand for R&D-focused investments; the firm also integrated advanced ESG screening into the index methodology during its inception to align with sustainable innovation trends. No major acquisitions, partnerships, or reorganizations have been announced for WRND specifically within the past year, though New York Life Investments continues to leverage its parent company's $600 billion-plus in assets under management for scale and distribution enhancements across its ETF platform.